Ryan Seidl, PA
Physician Assistant · Lexington, SCNPI 1821599143
Payments from drug & device makers
Across 139 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$355
- Johnson & Johnson$257
- AstraZeneca$217
- Bayer$200
- AbbVie$160
- Xeris Pharmaceuticals, Inc.$123
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 21 | $355 |
| Johnson & Johnson | 14 | $257 |
| AstraZeneca | 12 | $217 |
| Bayer | 9 | $200 |
| AbbVie | 9 | $160 |
| Xeris Pharmaceuticals, Inc. | 6 | $123 |
| Novo Nordisk | 8 | $121 |
| Sanofi-aventis U.S. LLC | 7 | $114 |
| GSK | 7 | $102 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $93 |
| Boehringer Ingelheim | 4 | $80 |
| Arbor Pharmaceuticals, Inc. | 4 | $68 |
| Optinose US, Inc. | 4 | $64 |
| Novartis | 3 | $52 |
| Abbott | 3 | $51 |
| Mylan Specialty L.p. | 1 | $48 |
| Dexcom, Inc. | 2 | $47 |
| Astellas Pharma US Inc | 3 | $43 |
| Exact Sciences | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Genentech USA, Inc. | 2 | $20 |
| Corcept Therapeutics | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Corvista Health, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
How this compares
$2,458 in reported general payments places this provider in the 80th percentile of 1,852 physician assistant providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 123 | $199,696 |
| EntrestoSacubitril/Valsartan | 55 | $56,014 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 50 | $36,182 |
| FarxigaDapagliflozin Propanediol | 39 | $35,826 |
| KerendiaFinerenone | 27 | $33,156 |
| JardianceEmpagliflozin | 29 | $29,478 |
| TrulicityDulaglutide | 19 | $28,830 |
| EliquisApixaban | 23 | $25,789 |
| XareltoRivaroxaban | 35 | $24,321 |
| OzempicSemaglutide | 16 | $16,880 |
| TrulancePlecanatide | 20 | $14,540 |
| TradjentaLinagliptin | 16 | $13,979 |
| LinzessLinaclotide | 13 | $8,014 |
| EdarbyclorAzilsartan Med/Chlorthalidone | 14 | $5,522 |
| MyrbetriqMirabegron | 11 | $4,796 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $355 | $228,526142 claims |
| AstraZenecaBreztri Aerosphere, Farxiga | $217 | $72,00789 claims |
| NovartisEntresto | $52 | $56,01455 claims |
| Boehringer IngelheimJardiance, Tradjenta | $80 | $43,45745 claims |
| BayerKerendia | $200 | $33,15627 claims |
| PfizerEliquis | $13 | $25,78923 claims |
| Johnson & JohnsonXarelto | $257 | $24,32135 claims |
| Novo NordiskOzempic | $121 | $16,88016 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $93 | $14,54020 claims |
| AbbVieLinzess | $160 | $8,01413 claims |
| Arbor Pharmaceuticals, Inc.Edarbyclor | $68 | $5,52214 claims |
| Astellas Pharma US IncMyrbetriq | $43 | $4,79611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,852 physician assistant providers in South Carolina.
Other physician assistant in Lexington
- Benjamin AddyWest Columbia$377K
- Michael OvercashCharleston$210K
- Allison LesterMt Pleasant$163K
- Nicole KeeterFort Mill$129K
- William YoungGreenville$117K
- Stephanie DavisAnderson$78K
- Vicki RobertsWest Columbia$77K
- Eric ShoupColumbia$74K
- Lauren OlsonNorth Charleston$62K
- Martha GreenSummerville$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.